Wegovy vs Mounjaro: Dose Conversion & Cost Analysis
Understanding What 1mg Wegovy Equals in Mounjaro Dosing
When considering what 1mg Wegovy compares to in Mounjaro, it's important to understand these are different medications with distinct mechanisms. Wegovy contains semaglutide (a GLP-1 receptor agonist), while Mounjaro contains tirzepatide (a dual GIP and GLP-1 receptor agonist). Direct dose conversions aren't clinically established, but patients switching from Mounjaro 5mg to Wegovy often transition to the 1mg dose under prescriber guidance. The 1mg Wegovy dose represents weeks 9-12 of escalation, where patients typically experience established appetite regulation and measurable progress towards their weight management goals.
Switching between these prescription-only medicines requires careful clinical oversight, as each has unique dosing schedules and escalation patterns. What makes 1mg Wegovy particularly attractive for switchers is its position in the dose escalation journey - patients have moved beyond initial tolerance-building phases and are approaching more substantial therapeutic effects. Your prescriber will assess your current Mounjaro dose, treatment response, and individual circumstances when determining the appropriate Wegovy starting point for a safe transition.
Switch & Save: Wegovy 1mg Pricing Advantages
The financial benefits of switching to Wegovy 1mg become clear when comparing costs. At £99.99 per pen, Wegovy 1mg offers competitive pricing, especially when considering our Advance Duo bundle (1mg + 1.7mg) for £269.99, providing a seamless bridge to higher doses. New customers can apply discount code FIRST40 at checkout to reach these prices, while returning customers use DOSE25. This pricing structure often represents savings compared to equivalent Mounjaro dosing, particularly for patients requiring long-term weight management support.
Our Progress Duo bundle (0.5mg & 1mg) at £189.99 allows patients stepping down from higher Mounjaro doses to find their optimal Wegovy level. For those wanting to maintain their 1mg dose, the Consistency 1mg bundle (×2 pens) costs £209.99, providing two months of supply with the convenience of fewer orders. The switch-and-save approach isn't just about immediate costs - it's about finding sustainable, long-term pricing that supports continuous treatment without financial barriers to your weight management journey.
Clinical Evidence Supporting Wegovy 1mg Effectiveness
Research from the STEP clinical trials demonstrates that patients taking Wegovy alongside diet and exercise may experience meaningful weight loss, with the 1mg dose representing a crucial mid-escalation phase. The STEP 1 trial (Wilding et al., NEJM, 2021) showed progressive benefits as patients advanced through dose escalation, with significant appetite suppression typically established by the 1mg phase. This evidence supports why many patients switching from other GLP-1 medications find 1mg an appropriate transition dose.
What makes the 1mg dose particularly relevant for switchers is that clinical trials showed measurable results emerging around weeks 9-12 of treatment. For patients transitioning from Mounjaro who have already established tolerance to GLP-1 pathway medications, starting Wegovy at 1mg (with prescriber guidance) may allow them to maintain therapeutic momentum while potentially reducing costs and accessing improved storage convenience.
How Wegovy 1mg Works Compared to Mounjaro Mechanisms
Understanding what 1mg Wegovy represents mechanistically helps explain its effectiveness for switchers. Wegovy works as a GLP-1 receptor agonist, mimicking natural fullness hormones to reduce appetite and promote satiety after smaller meals. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on the GLP-1 pathway, which many patients find equally effective for appetite control and weight management. The 1mg dose provides substantial GLP-1 receptor activation while remaining in the escalation phase, allowing further increases if needed. This focused mechanism may suit patients who experienced side effects with dual-pathway medications or prefer the simplicity of single-pathway treatment alongside their reduced-calorie diet and exercise programme.
Streamlined Ordering Process for Wegovy Switchers
Switching to Wegovy 1mg through EverydayMeds involves a straightforward 3-minute online clinical assessment covering your current medication history, treatment goals, and medical background. Our prescribers review applications within 3 working days (or 24 hours with express service), with particular expertise in supporting patients transitioning between weight management medications. Once approved, your Wegovy 1mg is dispatched via next-day cold-chain delivery, maintaining the 2-8°C storage requirements throughout transport. This process ensures continuity of care while providing the convenience of home delivery. Our GPhC-registered pharmacy (#9012878) maintains both Wegovy and Mounjaro stock, allowing seamless transitions without changing pharmacy providers or rebuilding clinical relationships.
Storage Advantages When Switching to Wegovy 1mg
One practical benefit of switching to Wegovy 1mg is superior storage flexibility compared to Mounjaro. While both medications require refrigeration at 2-8°C before first use, Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day limit. The FlexTouch pen delivery system is user-friendly and familiar to most patients switching from other injectable medications. This storage advantage particularly benefits frequent travellers or those with variable schedules. The 1mg dose represents an optimal balance in the escalation schedule - substantial enough for therapeutic effect while allowing further increases to 1.7mg and 2.4mg maintenance doses as clinically appropriate under prescriber supervision.
Why Patients Choose Wegovy 1mg Over Mounjaro Equivalents
Patient experiences suggest several reasons for switching to Wegovy 1mg from Mounjaro. Cost considerations often drive initial interest, but many patients appreciate Wegovy's focused GLP-1 mechanism and established clinical profile. The extensive STEP trial programme provides robust long-term data, with some patients preferring this evidence base when making treatment decisions. Additionally, Wegovy's storage advantages and pen design receive positive feedback from switchers seeking practical improvements to their weekly injection routine.
Supply consistency represents another factor, as Wegovy availability has stabilised following earlier shortages, providing patients with reliable access through established pharmacy networks like EverydayMeds. Some patients report different tolerability profiles between the medications, finding Wegovy 1mg suits their individual response patterns better. The switch often occurs during natural treatment evaluation points, such as completing initial dose escalation phases or experiencing supply interruptions with their current medication.
Complete Your Switch to Wegovy 1mg Today
Ready to explore switching to Wegovy 1mg? Our clinical team can assess your suitability and guide your transition from Mounjaro or other weight management medications. With new customer discount code FIRST40 and returning customer code DOSE25 applied at checkout, you'll access competitive pricing while maintaining clinical oversight throughout your switch. Visit our weight loss collection to begin your clinical assessment and discover how Wegovy 1mg could enhance your weight management journey. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medication with proper clinical support, making your switch both safe and cost-effective. Don't let medication costs or availability issues interrupt your progress - explore the Wegovy 1mg option today and continue moving towards your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
